Researchers discover a weakness in a rare cancer that could be exploited with drugs

by Rockefeller UniversitySome cancer cells cannot produce cholesterol, and instead build up an excess of squalene (pink)--a molecule that may help these dangerous cells thrive. Credit: Laboratory

Updated on: June 19,2024

Researchers discover a weakness in a rare cancer that could be exploited with drugs

by Rockefeller UniversitySome cancer cells cannot produce cholesterol, and instead build up an excess of squalene (pink)--a molecule that may help these dangerous cells thrive. Credit: Laboratory

Updated on:June 19,2024

Aging and cancer hallmarks as therapeutic targets

by Compuscript LtdCrosstalk between aging and cancer hallmarks. (a) Aging hallmarks are categorized into five groups based on correlation with cancer hallmarks. (b) Hallmarks shared between aging and

Updated on: January 04,2024

Aging and cancer hallmarks as therapeutic targets

by Compuscript LtdCrosstalk between aging and cancer hallmarks. (a) Aging hallmarks are categorized into five groups based on correlation with cancer hallmarks. (b) Hallmarks shared between aging and

Updated on:January 04,2024

The molecules behind metastasis

by Greta Friar,Whitehead Institute for Biomedical ResearchBreast cancer stem cells (red) that have reached the lung begin to divide into clusters that could become metastatic tumors. Credit: Art

Updated on: January 21,2024

The molecules behind metastasis

by Greta Friar,Whitehead Institute for Biomedical ResearchBreast cancer stem cells (red) that have reached the lung begin to divide into clusters that could become metastatic tumors. Credit: Art

Updated on:January 21,2024

Early menopause appears raise odds of breast cancer, study reports

by Dennis Thompson.Women who underwent menopause at an age younger than 46 were nearly twice as likely to havebreast cancercompared to others their age, researchers found.The study, appear

Updated on: August 27,2024

Early menopause appears raise odds of breast cancer, study reports

by Dennis Thompson.Women who underwent menopause at an age younger than 46 were nearly twice as likely to havebreast cancercompared to others their age, researchers found.The study, appear

Updated on:August 27,2024

Clinical trial shows efficacy for atezolizumab combined with carboplatin

byVanderbilt University Medical CenterCredit: CC0 Public DomainImmunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastati

Updated on: January 26,2024

Clinical trial shows efficacy for atezolizumab combined with carboplatin

byVanderbilt University Medical CenterCredit: CC0 Public DomainImmunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastati

Updated on:January 26,2024

Study calculates contribution of risk factors to cancer in the US

by American Cancer SocietyPopulation attributable fraction of cancer deaths by risk factor; men, women, and combined. Credit: American Cancer SocietyA new American Cancer Society study calculates

Updated on: July 02,2024

Study calculates contribution of risk factors to cancer in the US

by American Cancer SocietyPopulation attributable fraction of cancer deaths by risk factor; men, women, and combined. Credit: American Cancer SocietyA new American Cancer Society study calculates

Updated on:July 02,2024

ASCO endorses SIO guideline for integrative Tx in breast cancer

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treat

Updated on: March 30,2024

ASCO endorses SIO guideline for integrative Tx in breast cancer

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treat

Updated on:March 30,2024

Activation of a distinct genetic pathway can slow the progress of metastatic breast cancer

by Olivia Newton-John Cancer Research InstituteImmunofluorescent staining reveals activation of the BMP-Smad signaling pathway in metastatic breast cancer cells in response to BMP4 stimulation (left p

Updated on: December 20,2023

Activation of a distinct genetic pathway can slow the progress of metastatic breast cancer

by Olivia Newton-John Cancer Research InstituteImmunofluorescent staining reveals activation of the BMP-Smad signaling pathway in metastatic breast cancer cells in response to BMP4 stimulation (left p

Updated on:December 20,2023

New research identifies a potential treatment target for hepatoblastoma, the most common liver cancer in children

byElsevierLeft: Gross images of livers from mice transfected with β-catenin and YAP1(β-Y), β-catenin and YAP1 plus dominant negative HSF1 (dnHSF1-β-Y) and normal (control). Right: Liver to body

Updated on: January 13,2024

New research identifies a potential treatment target for hepatoblastoma, the most common liver cancer in children

byElsevierLeft: Gross images of livers from mice transfected with β-catenin and YAP1(β-Y), β-catenin and YAP1 plus dominant negative HSF1 (dnHSF1-β-Y) and normal (control). Right: Liver to body

Updated on:January 13,2024

Simple blood test for early detection of breast cancer

by National Cancer Research InstituteCredit: CC0 Public DomainBreast cancer could be detected up to five years before there are any clinical signs of it, using a blood test that identifies the body&#3

Updated on: April 20,2024

Simple blood test for early detection of breast cancer

by National Cancer Research InstituteCredit: CC0 Public DomainBreast cancer could be detected up to five years before there are any clinical signs of it, using a blood test that identifies the body&#3

Updated on:April 20,2024

Cell therapy appears safe and effective for lymphoma in remission

byUniversity of Miami Leonard M. Miller School of MedicineCredit: University of Miami Leonard M. Miller School of MedicineA study led by researchers at Sylvester Comprehensive Cancer Center at t

Updated on: January 26,2024

Cell therapy appears safe and effective for lymphoma in remission

byUniversity of Miami Leonard M. Miller School of MedicineCredit: University of Miami Leonard M. Miller School of MedicineA study led by researchers at Sylvester Comprehensive Cancer Center at t

Updated on:January 26,2024

BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

by Impact Journals LLCPatient examples of inverse correlation of BCMA and FLC changes during course of therapy. Credit: 2023 Springer et al.A new research paper was published inOncotarget, entit

Updated on: January 26,2024

BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

by Impact Journals LLCPatient examples of inverse correlation of BCMA and FLC changes during course of therapy. Credit: 2023 Springer et al.A new research paper was published inOncotarget, entit

Updated on:January 26,2024